Total amount: € 0,00
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,632
Online ISSN 1827-191X
Kogan A. 1, Berman M. 1, Stein M. 2, Vidne B. A. 1, Raanani E. 1
1 Department of Cardiothoracic Surgery Rabin Medical Center, Beilinson Campus Petach Tikva, Israel
2 Trauma Unit Rabin Medical Center, Beilinson Campus Petach Tikva, Israel
A 72-year-old patient was admitted for mitral valve replacement because of infective endocarditis. Severe intractable bleeding in the early postoperative period was successfully treated with recombinant activated factor VII (rFVIIa). Thereafter, recovery was uneventful, and the patient was discharged on postoperative day 16. The current clinical aspects and experience of rFVIIa use in cardiac surgery are discussed.